SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-018393
Filing Date
2024-02-22
Accepted
2024-02-22 06:32:54
Documents
13
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krtx-20240222.htm   iXBRL 8-K 39267
2 EX-99.1 krtx-ex99_1.htm EX-99.1 136625
  Complete submission text file 0000950170-24-018393.txt   300103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krtx-20240222.xsd EX-101.SCH 25012
14 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20240222_htm.xml XML 4747
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 24662206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)